デフォルト表紙
市場調査レポート
商品コード
1375911

医薬品eコマース市場規模、シェア、動向分析レポート:製品タイプ別、治療分野別、タイプ別、チャネルタイプ別、プラットフォーム別、地域別、セグメント予測、2023年~2030年

Pharma E-commerce Market Size, Share & Trends Analysis Report By Product Type (Vaccines, Specialty Care, Topical Medicines), By Therapeutic Areas, By Type, By Channel Type, By Platform, By Region, And Segment Forecasts, 2023 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 100 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.70円
医薬品eコマース市場規模、シェア、動向分析レポート:製品タイプ別、治療分野別、タイプ別、チャネルタイプ別、プラットフォーム別、地域別、セグメント予測、2023年~2030年
出版日: 2023年10月11日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医薬品eコマース市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界の医薬品eコマース市場規模は、2023年から2030年にかけて17.2%のCAGRを記録し、2030年までに2,778億7,000万米ドルに達する見込みです。

同市場は、医薬品eコマースプラットフォームが遠隔医療統合、処方箋管理、シンプルな注文プロセスなどの機能を盛り込むことで、消費者の利便性を優先し続けることが要因となって成長すると予想されています。COVID-19パンデミックの発生は、対面での接触に対する懸念を引き起こし、消費者がコロナウイルスへの曝露を避けるために処方薬、一般用医薬品(OTC)、ヘルスケア用品をオンラインストアで入手するよう促したことから、市場の成長に寄与すると予想されます。eコマース・プラットフォームがデータ分析と人工知能(AI)主導のアルゴリズムを積極的に活用し、顧客の医療プロファイル、購入履歴、嗜好に基づいて、OTCアイテムのパーソナライズされた推奨品を提供していることも、市場の成長に良い兆しをもたらしています。

製薬業界では、遠隔医療とeコマースの統合により、患者中心のヘルスケア・エコシステムが構築されます。この組み合わせは、ヘルスケアへのアクセスを改善し、服薬アドヒアランスを高め、利便性を向上させる。革新的なテクノロジーを活用し、オンデマンドのヘルスケア相談、個別の投薬管理、リアルタイムのモニタリングを提供することで、最終的にはデジタル時代における医療へのアクセス、品質、患者の体験を向上させる。遠隔医療プラットフォーム、モバイルヘルスアプリケーション、モノのインターネット(IoT)デバイス、AI主導型ソリューションなどのデジタル技術の急速な拡大により、継続的でユーザーフレンドリーなヘルスケアサービスをオンラインで提供することがより身近になりました。

偽造医薬品の密売に意図せず関与したと判断されたオンライン薬局は、大きな法的影響を受ける。さらに、このような事例はその評判を著しく傷つける。その結果、風評被害は事業の存続に広範囲かつ長期的な悪影響を及ぼす可能性があります。例えば、偽造医薬品のインターネット販売を減少させるために、国際刑事警察機構(INTERPOL)が毎年主導している国際的な活動は、「パンゲア作戦」として知られています。違法なオンライン薬局を減らすこのキャンペーンには、APACの数カ国が参加しています。インド、中国、オーストラリアなどの当局は、すでに大量の偽造医薬品を押収し、その売買に関与した人物を逮捕しています。

医薬品eコマース分野は、ヘルスケアへの迅速なアクセスや服薬コンプライアンスの向上という点で、将来的に大きな発展とイノベーションをもたらす可能性を秘めています。予測期間中、医療記録の統合、規制の整備、パートナーシップ、患者のエンパワーメント、世界の拡大によって形成されると予想されます。ヘルスケア提供におけるアクセシビリティ、パーソナライゼーション、ポテンシャリティを高めるためにデジタル技術を活用することで、患者中心のケアを改善することに引き続き重点が置かれます。

医薬品eコマース市場レポートハイライト:

  • 製品タイプ別では、ワクチン分野が予測期間で最も高いCAGR 19.1%を記録する見込みです。医薬品eコマース・プラットフォームは、顧客がさまざまなブランドから入手可能なワクチンを調べたり、ワクチン接種のスケジュールを評価したり、予約を入れたりするためのユーザーフレンドリーなインターフェースを提供します。医薬品eコマース・プラットフォームは、肝炎、インフルエンザ、破傷風などの従来のワクチンや、新興感染症用の新しいワクチンなど、予防可能な病気や健康問題に対するより多様なワクチンを含むワクチンの提供を増やすと予想されます。
  • 治療分野別では、免疫系疾患分野が予測期間中に20.0%のCAGRを記録すると予想されます。同分野の成長は、免疫学に関する継続的な研究と様々な治療法の開発により、免疫系疾患の治療選択肢に対する理解が深まったことに起因すると考えられます。
  • タイプ別に見ると、処方薬セグメントは予測期間中に19.7%という最も高いCAGRを記録すると予想されます。同分野の成長は、世界の急速な高齢化により、処方箋医薬品への要求が高まっていることに起因しています。eコマース・プラットフォームは、高齢者が医薬品のニーズを管理するのに便利な選択肢を提供します。ヘルスケア・ビジネスは患者中心のケアへと徐々に移行しており、eコマース・サイトは患者が医療上の意思決定や薬剤管理に積極的に参加するのに役立ちます。
  • チャネルの種類別では、B2Cセグメントが予測期間中に18.3%という最高のCAGRを記録すると予想されています。このセグメントの成長は、OTC医薬品、栄養補助食品、医療機器、ウェルネス製品、その他のパーソナルケア製品など、医療用医薬品以外の幅広いヘルスケア製品を含む製品提供の拡大に起因しています。
  • プラットフォーム別では、メーカー直営マーケットプレース部門が予測期間で最も高いCAGR 19.4%を記録すると予想されます。このセグメントの成長は、製薬企業が従来の流通チャネルを迂回し、メーカー直営マーケットプレースを通じて顧客に直接販売することに重点を置いていることに起因しています。
  • 北米地域市場は、予測期間中に19.4%という最も高いCAGRを記録すると予想されています。eコマース・プラットフォームに遠隔医療ソリューションを組み込むことは、北米の市場成長を促進する上で極めて重要です。遠隔医療相談では、eコマース・チャネルを通じてe処方箋を取得し、医薬品を注文するオプションが頻繁に使用されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 世界の医薬品eコマース市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
  • 業界のバリューチェーン分析
  • 市場力学
    • 市場促進要因分析
    • 市場の抑制要因/課題の分析
    • 市場機会分析
  • ビジネス環境分析ツール
    • ポーターのファイブフォース分析
    • PEST分析

第4章 世界の医薬品eコマース市場の製品タイプ展望

  • 製品タイプ別の世界の医薬品eコマース市場シェア、2022年および2030年
  • ワクチン
  • スペシャルティケア
  • 外用薬
  • その他

第5章 世界の医薬品eコマース市場の治療領域展望

  • 治療分野別の世界の医薬品eコマース市場シェア、2022年および2030年
  • 糖尿病
  • 免疫系疾患
  • 心血管疾患
  • 神経変性疾患
  • がん
  • HIV/エイズ
  • その他

第6章 世界の医薬品eコマース市場タイプ展望

  • タイプ別の世界の医薬品eコマース市場シェア、2022年と2030年
  • 処方薬
  • 店頭販売(OTC)

第7章 世界の医薬品eコマース市場チャネルタイプ展望

  • チャネルタイプ別の世界の医薬品eコマース市場シェア、2022年と2030年
  • B2B
  • B2B2B
  • B2B2C
  • B2C

第8章 世界の医薬品eコマース市場プラットフォームタイプの展望

  • プラットフォームタイプ別の世界の医薬品eコマース市場シェア、2022年および2030年
  • メーカー所有のデジタルコマース
  • 流通業者/卸売業者が所有するデジタルコマース
  • メーカー所有のマーケットプレース
  • サードパーティマーケットプレイス
  • 小売り

第9章 世界の医薬品eコマース市場:地域別展望

  • 地域別の世界の医薬品eコマース市場シェア、2022年および2030年
  • 北米
    • 市場推計・予測、2018~2030年
    • 製品タイプ別、2018~2030年
    • 治療領域別、2018~2030年
    • 種類別、2018~2030年
    • チャネルタイプ別、2018~2030年
    • プラットフォーム別、2018~2030年
    • 米国
    • カナダ
  • 欧州
    • 市場推計・予測、2018~2030年
    • 製品タイプ別、2018~2030年
    • 治療領域別、2018~2030年
    • 種類別、2018~2030年
    • チャネルタイプ別、2018~2030年
    • プラットフォーム別、2018~2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ロシア
    • ポーランド
    • アルジェリア
    • トルコ
  • アジア太平洋地域
    • 市場推計・予測、2018~2030年
    • 製品タイプ別、2018~2030年
    • 治療領域別、2018~2030年
    • 種類別、2018~2030年
    • チャネルタイプ別、2018~2030年
    • プラットフォーム別、2018~2030年
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • インドネシア
  • ラテンアメリカ
    • 市場推計・予測、2018~2030年
    • 製品タイプ別、2018~2030年
    • 治療領域別、2018~2030年
    • 種類別、2018~2030年
    • チャネルタイプ別、2018~2030年
    • プラットフォーム別、2018~2030年
    • ブラジル
    • メキシコ
  • 中東とアフリカ
    • 市場推計・予測、2018~2030年
    • 製品タイプ別、2018~2030年
    • 治療領域別、2018~2030年
    • 種類別、2018~2030年
    • チャネルタイプ別、2018~2030年
    • プラットフォーム別、2018~2030年
    • サウジアラビア
    • 南アフリカ

第10章 競合情勢

  • 企業の分類(成熟企業、新興企業)
  • Company Share Analysis, 2022
  • ヒートマップ分析
  • 戦略マッピング
  • 企業プロファイル(会社概要、業績、製品概要、戦略的取り組み)
    • Amazon, Inc
    • Apotek
    • CVS Health
    • DocMorris
    • Express Scripts
    • Giant Eagle, Inc.
    • L Rowland &Co(Retail)Ltd
    • McKesson Corporation
    • Netmeds Marketplace Ltd.
    • Optum, Inc.
    • SHOP-APOTHEKE EUROPE NV
    • The Kroger Co.
    • Walmart
    • Walgreens Boots Alliance, Inc.
    • Zur Rose Group AG
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 Global Pharma E-commerce market, 2018 - 2030 (Revenue, USD Billion)
  • Table 3 Global Pharma E-commerce market, by region, 2018 - 2030 (Revenue, USD Billion)
  • Table 4 Global Pharma E-commerce market, by product type, 2018 - 2030 (Revenue, USD Billion)
  • Table 5 Global Pharma E-commerce market, by therapeutic areas, 2018 - 2030 (Revenue, USD Billion)
  • Table 6 Global Pharma E-commerce market, by type, 2018 - 2030 (Revenue, USD Billion)
  • Table 7 Global Pharma E-commerce market, by channel type, 2018 - 2030 (Revenue, USD Billion)
  • Table 8 Global Pharma E-commerce market, by platform, 2018 - 2030 (Revenue, USD Billion)
  • Table 9 North America Pharma E-commerce market, by product type 2018 - 2030 (Revenue, USD Billion)
  • Table 10 North America Pharma E-commerce market, by therapeutic areas, 2018 - 2030 (Revenue, USD Billion)
  • Table 11 North America Pharma E-commerce market, by type 2018 - 2030 (Revenue, USD Billion)
  • Table 12 North America Pharma E-commerce market, by channel type 2018 - 2030 (Revenue, USD Billion)
  • Table 13 North America Pharma E-commerce market, by platform 2018 - 2030 (Revenue, USD Billion)
  • Table 14 U.S. Pharma E-commerce market, by product type 2018 - 2030 (Revenue, USD Billion)
  • Table 15 U.S. Pharma E-commerce market, by therapeutic areas, 2018 - 2030 (Revenue, USD Billion)
  • Table 16 U.S. Pharma E-commerce market, by type 2018 - 2030 (Revenue, USD Billion)
  • Table 17 U.S. Pharma E-commerce market, by channel type 2018 - 2030 (Revenue, USD Billion)
  • Table 18 U.S. Pharma E-commerce market, by platform 2018 - 2030 (Revenue, USD Billion)
  • Table 19 Canada Pharma E-commerce market, by product type 2018 - 2030 (Revenue, USD Billion)
  • Table 20 Canada Pharma E-commerce market, by therapeutic areas, 2018 - 2030 (Revenue, USD Billion)
  • Table 21 Canada Pharma E-commerce market, by type 2018 - 2030 (Revenue, USD Billion)
  • Table 22 Canada Pharma E-commerce market, by channel type 2018 - 2030 (Revenue, USD Billion)
  • Table 23 Canada Pharma E-commerce market, by platform 2018 - 2030 (Revenue, USD Billion)
  • Table 24 Europe Pharma E-commerce market, by product type 2018 - 2030 (Revenue, USD Billion)
  • Table 25 Europe Pharma E-commerce market, by therapeutic areas, 2018 - 2030 (Revenue, USD Billion)
  • Table 26 Europe Pharma E-commerce market, by type 2018 - 2030 (Revenue, USD Billion)
  • Table 27 Europe Pharma E-commerce market, by channel type 2018 - 2030 (Revenue, USD Billion)
  • Table 28 Europe Pharma E-commerce market, by platform 2018 - 2030 (Revenue, USD Billion)
  • Table 29 UK Pharma E-commerce market, by product type 2018 - 2030 (Revenue, USD Billion)
  • Table 30 UK Pharma E-commerce market, by therapeutic areas, 2018 - 2030 (Revenue, USD Billion)
  • Table 31 UK Pharma E-commerce market, by type 2018 - 2030 (Revenue, USD Billion)
  • Table 32 UK Pharma E-commerce market, by channel type 2018 - 2030 (Revenue, USD Billion)
  • Table 33 UK Pharma E-commerce market, by platform 2018 - 2030 (Revenue, USD Billion)
  • Table 34 Germany Pharma E-commerce market, by product type 2018 - 2030 (Revenue, USD Billion)
  • Table 35 Germany Pharma E-commerce market, by therapeutic areas, 2018 - 2030 (Revenue, USD Billion)
  • Table 36 Germany Pharma E-commerce market, by type 2018 - 2030 (Revenue, USD Billion)
  • Table 37 Germany Pharma E-commerce market, by channel type 2018 - 2030 (Revenue, USD Billion)
  • Table 38 Germany Pharma E-commerce market, by platform 2018 - 2030 (Revenue, USD Billion)
  • Table 39 France Pharma E-commerce market, by product type 2018 - 2030 (Revenue, USD Billion)
  • Table 40 France Pharma E-commerce market, by therapeutic areas, 2018 - 2030 (Revenue, USD Billion)
  • Table 41 France Pharma E-commerce market, by type 2018 - 2030 (Revenue, USD Billion)
  • Table 42 France Pharma E-commerce market, by channel type 2018 - 2030 (Revenue, USD Billion)
  • Table 43 France Pharma E-commerce market, by platform 2018 - 2030 (Revenue, USD Billion)
  • Table 44 Italy Pharma E-commerce market, by product type 2018 - 2030 (Revenue, USD Billion)
  • Table 45 Italy Pharma E-commerce market, by therapeutic areas, 2018 - 2030 (Revenue, USD Billion)
  • Table 46 Italy Pharma E-commerce market, by type 2018 - 2030 (Revenue, USD Billion)
  • Table 47 Italy Pharma E-commerce market, by channel type 2018 - 2030 (Revenue, USD Billion)
  • Table 48 Italy Pharma E-commerce market, by platform 2018 - 2030 (Revenue, USD Billion)
  • Table 49 Spain Pharma E-commerce market, by product type 2018 - 2030 (Revenue, USD Billion)
  • Table 50 Spain Pharma E-commerce market, by therapeutic areas, 2018 - 2030 (Revenue, USD Billion)
  • Table 51 Spain Pharma E-commerce market, by type 2018 - 2030 (Revenue, USD Billion)
  • Table 52 Spain Pharma E-commerce market, by channel type 2018 - 2030 (Revenue, USD Billion)
  • Table 53 Spain Pharma E-commerce market, by platform 2018 - 2030 (Revenue, USD Billion)
  • Table 54 Russia Pharma E-commerce market, by product type 2018 - 2030 (Revenue, USD Billion)
  • Table 55 Russia Pharma E-commerce market, by therapeutic areas, 2018 - 2030 (Revenue, USD Billion)
  • Table 56 Russia Pharma E-commerce market, by type 2018 - 2030 (Revenue, USD Billion)
  • Table 57 Russia Pharma E-commerce market, by channel type 2018 - 2030 (Revenue, USD Billion)
  • Table 58 Russia Pharma E-commerce market, by platform 2018 - 2030 (Revenue, USD Billion)
  • Table 59 Poland Pharma E-commerce market, by product type 2018 - 2030 (Revenue, USD Billion)
  • Table 60 Poland Pharma E-commerce market, by therapeutic areas, 2018 - 2030 (Revenue, USD Billion)
  • Table 61 Poland Pharma E-commerce market, by type 2018 - 2030 (Revenue, USD Billion)
  • Table 62 Poland Pharma E-commerce market, by channel type 2018 - 2030 (Revenue, USD Billion)
  • Table 63 Poland Pharma E-commerce market, by platform 2018 - 2030 (Revenue, USD Billion)
  • Table 64 Algeria Pharma E-commerce market, by product type 2018 - 2030 (Revenue, USD Billion)
  • Table 65 Algeria Pharma E-commerce market, by therapeutic areas, 2018 - 2030 (Revenue, USD Billion)
  • Table 66 Algeria Pharma E-commerce market, by type 2018 - 2030 (Revenue, USD Billion)
  • Table 67 Algeria Pharma E-commerce market, by channel type 2018 - 2030 (Revenue, USD Billion)
  • Table 68 Algeria Pharma E-commerce market, by platform 2018 - 2030 (Revenue, USD Billion)
  • Table 69 Turkey Pharma E-commerce market, by product type 2018 - 2030 (Revenue, USD Billion)
  • Table 70 Turkey Pharma E-commerce market, by therapeutic areas, 2018 - 2030 (Revenue, USD Billion)
  • Table 71 Turkey Pharma E-commerce market, by type 2018 - 2030 (Revenue, USD Billion)
  • Table 72 Turkey Pharma E-commerce market, by channel type 2018 - 2030 (Revenue, USD Billion)
  • Table 73 Turkey Pharma E-commerce market, by platform 2018 - 2030 (Revenue, USD Billion)
  • Table 74 Asia Pacific Pharma E-commerce market, by product type 2018 - 2030 (Revenue, USD Billion)
  • Table 75 Asia Pacific Pharma E-commerce market, by therapeutic areas, 2018 - 2030 (Revenue, USD Billion)
  • Table 76 Asia Pacific Pharma E-commerce market, by type 2018 - 2030 (Revenue, USD Billion)
  • Table 77 Asia Pacific Pharma E-commerce market, by channel type 2018 - 2030 (Revenue, USD Billion)
  • Table 78 Asia Pacific Pharma E-commerce market, by platform 2018 - 2030 (Revenue, USD Billion)
  • Table 79 China Pharma E-commerce market, by product type 2018 - 2030 (Revenue, USD Billion)
  • Table 80 China Pharma E-commerce market, by therapeutic areas, 2018 - 2030 (Revenue, USD Billion)
  • Table 81 China Pharma E-commerce market, by type 2018 - 2030 (Revenue, USD Billion)
  • Table 82 China Pharma E-commerce market, by channel type 2018 - 2030 (Revenue, USD Billion)
  • Table 83 China Pharma E-commerce market, by platform 2018 - 2030 (Revenue, USD Billion)
  • Table 84 India Pharma E-commerce market, by product type 2018 - 2030 (Revenue, USD Billion)
  • Table 85 India Pharma E-commerce market, by therapeutic areas, 2018 - 2030 (Revenue, USD Billion)
  • Table 86 India Pharma E-commerce market, by type 2018 - 2030 (Revenue, USD Billion)
  • Table 87 India Pharma E-commerce market, by channel type 2018 - 2030 (Revenue, USD Billion)
  • Table 88 India Pharma E-commerce market, by platform 2018 - 2030 (Revenue, USD Billion)
  • Table 89 Japan Pharma E-commerce market, by product type 2018 - 2030 (Revenue, USD Billion)
  • Table 90 Japan Pharma E-commerce market, by therapeutic areas, 2018 - 2030 (Revenue, USD Billion)
  • Table 91 Japan Pharma E-commerce market, by type 2018 - 2030 (Revenue, USD Billion)
  • Table 92 Japan Pharma E-commerce market, by channel type 2018 - 2030 (Revenue, USD Billion)
  • Table 93 Japan Pharma E-commerce market, by platform 2018 - 2030 (Revenue, USD Billion)
  • Table 94 South Korea Pharma E-commerce market, by product type 2018 - 2030 (Revenue, USD Billion)
  • Table 95 South Korea Pharma E-commerce market, by therapeutic areas, 2018 - 2030 (Revenue, USD Billion)
  • Table 96 South Korea Pharma E-commerce market, by type 2018 - 2030 (Revenue, USD Billion)
  • Table 97 South Korea Pharma E-commerce market, by channel type 2018 - 2030 (Revenue, USD Billion)
  • Table 98 South Korea Pharma E-commerce market, by platform 2018 - 2030 (Revenue, USD Billion)
  • Table 99 Australia Pharma E-commerce market, by product type 2018 - 2030 (Revenue, USD Billion)
  • Table 100 Australia Pharma E-commerce market, by therapeutic areas, 2018 - 2030 (Revenue, USD Billion)
  • Table 101 Australia Pharma E-commerce market, by type 2018 - 2030 (Revenue, USD Billion)
  • Table 102 Australia Pharma E-commerce market, by channel type 2018 - 2030 (Revenue, USD Billion)
  • Table 103 Australia Pharma E-commerce market, by platform 2018 - 2030 (Revenue, USD Billion)
  • Table 104 Indonesia Pharma E-commerce market, by product type 2018 - 2030 (Revenue, USD Billion)
  • Table 105 Indonesia Pharma E-commerce market, by therapeutic areas, 2018 - 2030 (Revenue, USD Billion)
  • Table 106 Indonesia Pharma E-commerce market, by type 2018 - 2030 (Revenue, USD Billion)
  • Table 107 Indonesia Pharma E-commerce market, by channel type 2018 - 2030 (Revenue, USD Billion)
  • Table 108 Indonesia Pharma E-commerce market, by platform 2018 - 2030 (Revenue, USD Billion)
  • Table 109 Latin America Pharma E-commerce market, by product type 2018 - 2030 (Revenue, USD Billion)
  • Table 110 Latin America Pharma E-commerce market, by therapeutic areas, 2018 - 2030 (Revenue, USD Billion)
  • Table 111 Latin America Pharma E-commerce market, by type 2018 - 2030 (Revenue, USD Billion)
  • Table 112 Latin America Pharma E-commerce market, by channel type 2018 - 2030 (Revenue, USD Billion)
  • Table 113 Latin America Pharma E-commerce market, by platform 2018 - 2030 (Revenue, USD Billion)
  • Table 114 Brazil Pharma E-commerce market, by product type 2018 - 2030 (Revenue, USD Billion)
  • Table 115 Brazil Pharma E-commerce market, by therapeutic areas, 2018 - 2030 (Revenue, USD Billion)
  • Table 116 Brazil Pharma E-commerce market, by type 2018 - 2030 (Revenue, USD Billion)
  • Table 117 Brazil Pharma E-commerce market, by channel type 2018 - 2030 (Revenue, USD Billion)
  • Table 118 Brazil Pharma E-commerce market, by platform 2018 - 2030 (Revenue, USD Billion)
  • Table 119 Mexico Pharma E-commerce market, by product type 2018 - 2030 (Revenue, USD Billion)
  • Table 120 Mexico Pharma E-commerce market, by therapeutic areas, 2018 - 2030 (Revenue, USD Billion)
  • Table 121 Mexico Pharma E-commerce market, by type 2018 - 2030 (Revenue, USD Billion)
  • Table 122 Mexico Pharma E-commerce market, by channel type 2018 - 2030 (Revenue, USD Billion)
  • Table 123 Mexico Pharma E-commerce market, by platform 2018 - 2030 (Revenue, USD Billion)
  • Table 124 Middle East & Africa Pharma E-commerce market, by product type 2018 - 2030 (Revenue, USD Billion)
  • Table 125 Middle East & Africa Pharma E-commerce market, by therapeutic areas, 2018 - 2030 (Revenue, USD Billion)
  • Table 126 Middle East & Africa Pharma E-commerce market, by type 2018 - 2030 (Revenue, USD Billion)
  • Table 127 Middle East & Africa Pharma E-commerce market, by channel type 2018 - 2030 (Revenue, USD Billion)
  • Table 128 Middle East & Africa Pharma E-commerce market, by platform 2018 - 2030 (Revenue, USD Billion)
  • Table 129 Saudi Arabia Pharma E-commerce market, by product type 2018 - 2030 (Revenue, USD Billion)
  • Table 130 Saudi Arabia Pharma E-commerce market, by therapeutic areas, 2018 - 2030 (Revenue, USD Billion)
  • Table 131 Saudi Arabia Pharma E-commerce market, by type 2018 - 2030 (Revenue, USD Billion)
  • Table 132 Saudi Arabia Pharma E-commerce market, by channel type 2018 - 2030 (Revenue, USD Billion)
  • Table 133 Saudi Arabia Pharma E-commerce market, by platform 2018 - 2030 (Revenue, USD Billion)
  • Table 134 South Africa Pharma E-commerce market, by product type 2018 - 2030 (Revenue, USD Billion)
  • Table 135 South Africa Pharma E-commerce market, by therapeutic areas, 2018 - 2030 (Revenue, USD Billion)
  • Table 136 South Africa Pharma E-commerce market, by type 2018 - 2030 (Revenue, USD Billion)
  • Table 137 South Africa Pharma E-commerce market, by channel type 2018 - 2030 (Revenue, USD Billion)
  • Table 138 South Africa Pharma E-commerce market, by platform 2018 - 2030 (Revenue, USD Billion)

List of Figures

  • Fig. 1 Pharma E-commerce market segmentation
  • Fig. 2 Methodology
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Information analysis
  • Fig. 5 Data Analysis Model
  • Fig. 6 Data Validation & Publishing
  • Fig. 7 Pharma E-commerce: Market Snapshot
  • Fig. 8 Pharma E-commerce: Segment Snapshot
  • Fig. 9 Pharma E-commerce: Competitive Landscape Snapshot
  • Fig. 10 Pharma E-commerce Market Lineage Outlook
  • Fig. 11 Pharma E-commerce market: Value chain analysis
  • Fig. 12 Market driver analysis
  • Fig. 13 Market restraint analysis
  • Fig. 14 Market opportunity analysis
  • Fig. 15 Pharma E-commerce market: Porter's five forces analysis
  • Fig. 16 Pharma E-commerce market: PEST analysis
  • Fig. 17 Pharma E-commerce market analysis: Product Type segment analysis
  • Fig. 18 Pharma E-commerce market analysis: Therapeutic Areas segment analysis
  • Fig. 19 Pharma E-commerce market analysis: Type segment analysis
  • Fig. 20 Pharma E-commerce market analysis: Channel Type segment analysis
  • Fig. 21 Pharma E-commerce market analysis: Platform segment analysis
目次
Product Code: GVR-4-68040-135-1

Pharma E-commerce Market Growth & Trends:

The global pharma E-commerce market size is expected to reach USD 277.87 billion by 2030, registering a CAGR of 17.2% from 2023 to 2030, according to a recent report from Grand View Research, Inc.. The market is expected to grow attributed to the pharma e-commerce platforms continuing to prioritize consumer convenience by including features such as telemedicine integration, prescription management, and simple ordering processes. The outbreak of the COVID-19 pandemic, which triggered concerns over in-person contacts and prompted consumers to obtain prescription drugs, Over-The-Counter (OTC) drugs, and healthcare supplies via online stores to avoid any coronavirus exposure, is expected to contribute to the growth of the market. The aggressive use of data analytics and Artificial Intelligence (AI)-driven algorithms by e-commerce platforms to deliver personalized recommendations for OTC items based on customers' medical profiles, purchase histories, and preferences also bode well for the growth of the market.

In the pharma industry, the integration of telemedicine with e-commerce creates a patient-centric healthcare ecosystem. The combination improves access to healthcare, increases drug adherence, and enhances convenience. It utilizes innovative technology to provide on-demand healthcare consultations, individualized medication management, and real-time monitoring, ultimately improving access to medical care, quality, and patient experiences in the digital age. The rapid expansion of digital technologies such as telemedicine platforms, mobile health applications, Internet of Things (IoT) devices, and AI-driven solutions have made it more accessible to provide continuous and user-friendly healthcare services online.

Online pharmacies determined to be unintentionally involved in the trafficking of counterfeit pharmaceuticals suffer major legal consequences. Moreover, such instances harm their reputation significantly. The resulting reputational damage can have far-reaching and long-term detrimental implications for the viability of a business. For instance, the annual international operation led by INTERPOL to reduce the internet selling of counterfeit medications is known as Operation Pangea. Several APAC countries are involved in this campaign to reduce illegal online pharmacies. Authorities in nations such as India, China, and Australia have already confiscated large quantities of counterfeit pharmaceuticals and arrested persons involved in their trafficking.

The pharmaceutical e-commerce sector has the potential for massive development and innovation in the future in terms of quick access to healthcare and increased medication compliance. It is expected to be shaped by health record integration, regulatory development, partnerships, patient empowerment, and global expansion over the forecasted period. The emphasis continues to be on improving patient-centered care by leveraging digital technologies to increase accessibility, personalization, and potency in healthcare delivery.

Pharma E-commerce Market Report Highlights:

  • Based on product type, the vaccines segment is expected to register the highest CAGR of 19.1% over the forecast period. Pharma e-commerce platforms provide a user-friendly interface for customers to examine the vaccines available from different brands, evaluate vaccination timelines, and schedule appointments. Pharma e-commerce platforms are anticipated to increase their vaccine offerings to include a greater variety of vaccines for preventable illnesses and health issues, such as conventional vaccines for hepatitis, influenza, and tetanus; and new vaccines for emerging infectious diseases
  • Based on therapeutic area, the immune-system disease segment is expected to register the highest CAGR of 20.0% over the forecast period. The growth of the segment can be attributed to the continued research on immunology and the development of various treatments, which can lead to a better understanding of therapeutic options for immune-system illnesses
  • Based on type, the prescription medicine segment is expected to register the highest CAGR of 19.7% over the forecast period. The growth of the segment can be attributed to the rapidly aging world increasing the requirement for prescription pharmaceuticals. E-commerce platforms offer a convenient alternative for senior citizens to manage their drug needs. The healthcare business is progressively moving toward patient-centered care, and e-commerce sites can help patients actively participate in their medical decisions and drug management.
  • Based on channel type, the B2C segment is expected to register the highest CAGR of 18.3% over the forecast period. The growth of the segment can be attributed to the expanding product offerings encompassing a broader range of healthcare products other than prescription pharmaceuticals, including OTC medications, nutritional supplements, medical equipment, wellness products, and other personal care items
  • Based on platform, the manufacturer-owned marketplace segment is expected to register the highest CAGR of 19.4% over the forecast period. The growth of the segment can be attributed to the strong emphasis pharma businesses are putting on selling directly to customers through manufacturer-owned marketplaces, bypassing conventional distribution channels
  • The North American regional market is expected to register the highest CAGR of 19.4% over the forecast period. The incorporation of telehealth solutions within e-commerce platforms has been crucial in driving the growth of the market in North America. Telehealth consultations frequently involve the option to acquire e-prescriptions and order drugs via e-commerce channels

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Methodology Segmentation & Scope
  • 1.2. Information procurement
    • 1.2.1. Purchased database
    • 1.2.2. GVR's internal database
    • 1.2.3. Secondary sources & third-party perspectives
    • 1.2.4. Primary research
  • 1.3. Information analysis
    • 1.3.1. Data analysis models
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Global Pharma E-commerce Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
  • 3.2. Industry Value Chain Analysis
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint/Challenge Analysis
    • 3.3.3. Market Opportunity Analysis
  • 3.4. Business Environment Analysis Tools
    • 3.4.1. Porter's Five Forces Analysis
    • 3.4.2. PEST Analysis

Chapter 4. Global Pharma E-commerce Market Product Type Outlook

  • 4.1. Global Pharma E-commerce Market Share by Product Type, 2022 & 2030 (Revenue, USD Billion)
  • 4.2. Vaccines
    • 4.2.1. Market size estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 4.3. Specialty Care
    • 4.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 4.4. Topical Medicines
    • 4.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 4.5. Others
    • 4.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)

Chapter 5. Global Pharma E-commerce Market Therapeutic Areas Outlook

  • 5.1. Global Pharma E-commerce Market Share by Therapeutic Areas, 2022 & 2030 (Revenue, USD Billion)
  • 5.2. Diabetes
    • 5.2.1. Market size estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 5.3. Immune-system Diseases
    • 5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 5.4. Cardiovascular Diseases
    • 5.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 5.5. Neurodegenerative Diseases
    • 5.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 5.6. Cancer
    • 5.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 5.7. HIV/AIDS
    • 5.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 5.8. Others
    • 5.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)

Chapter 6. Global Pharma E-commerce Market Type Outlook

  • 6.1. Global Pharma E-commerce Market Share by Type, 2022 & 2030 (Revenue, USD Billion)
  • 6.2. Prescription Medicine
    • 6.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 6.3. Over-the-Counter (OTC)
    • 6.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)

Chapter 7. Global Pharma E-commerce Market Channel Type Outlook

  • 7.1. Global Pharma E-commerce Market Share by Channel Type, 2022 & 2030 (Revenue, USD Billion)
  • 7.2. B2B
    • 7.2.1. Market size estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 7.3. B2B2B
    • 7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.4. B2B2C
    • 7.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 7.5. B2C
    • 7.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)

Chapter 8. Global Pharma E-commerce Market Market Platform Type Outlook

  • 8.1. Global Pharma E-commerce Market Share by Platform Type, 2022 & 2030 (Revenue, USD Billion)
  • 8.2. Manufacturer-owned Digital Commerce
    • 8.2.1. Market size estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 8.3. Distributor/Wholesaler-owned Digital Commerce
    • 8.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 8.4. Manufacturer-owned Marketplace
    • 8.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 8.5. Third Party Market Place
    • 8.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 8.6. Retail
    • 8.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)

Chapter 9. Global Pharma E-commerce Market: Regional Outlook

  • 9.1. Global Pharma E-commerce Market Share by Region, 2022 & 2030 (Revenue, USD Billion)
  • 9.2. North America
    • 9.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 9.2.2. Market estimates and forecast by product type, 2018 - 2030 (Revenue, USD Billion)
    • 9.2.3. Market estimates and forecast by therapeutic Areas, 2018 - 2030 (Revenue, USD Billion)
    • 9.2.4. Market estimates and forecast by type, 2018 - 2030 (Revenue, USD Billion)
    • 9.2.5. Market estimates and forecast by channel type, 2018 - 2030 (Revenue, USD Billion)
    • 9.2.6. Market estimates and forecast by platform, 2018 - 2030 (Revenue, USD Billion)
    • 9.2.7. U.S.
      • 9.2.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 9.2.7.2. Market estimates and forecast by product type, 2018 - 2030 (Revenue, USD Billion)
      • 9.2.7.3. Market estimates and forecast by therapeutic Areas, 2018 - 2030 (Revenue, USD Billion)
      • 9.2.7.4. Market estimates and forecast by type, 2018 - 2030 (Revenue, USD Billion)
      • 9.2.7.5. Market estimates and forecast by channel type, 2018 - 2030 (Revenue, USD Billion)
      • 9.2.7.6. Market estimates and forecast by platform, 2018 - 2030 (Revenue, USD Billion)
    • 9.2.8. Canada
      • 9.2.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 9.2.8.2. Market estimates and forecast by product type, 2018 - 2030 (Revenue, USD Billion)
      • 9.2.8.3. Market estimates and forecast by therapeutic Areas, 2018 - 2030 (Revenue, USD Billion)
      • 9.2.8.4. Market estimates and forecast by type, 2018 - 2030 (Revenue, USD Billion)
      • 9.2.8.5. Market estimates and forecast by channel type, 2018 - 2030 (Revenue, USD Billion)
      • 9.2.8.6. Market estimates and forecast by platform, 2018 - 2030 (Revenue, USD Billion)
  • 9.3. Europe
    • 9.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 9.3.2. Market estimates and forecast by product type, 2018 - 2030 (Revenue, USD Billion)
    • 9.3.3. Market estimates and forecast by therapeutic Areas, 2018 - 2030 (Revenue, USD Billion)
    • 9.3.4. Market estimates and forecast by type, 2018 - 2030 (Revenue, USD Billion)
    • 9.3.5. Market estimates and forecast by channel type, 2018 - 2030 (Revenue, USD Billion)
    • 9.3.6. Market estimates and forecast by platform, 2018 - 2030 (Revenue, USD Billion)
    • 9.3.7. UK
      • 9.3.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.7.2. Market estimates and forecast by product type, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.7.3. Market estimates and forecast by therapeutic Areas, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.7.4. Market estimates and forecast by type, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.7.5. Market estimates and forecast by channel type, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.7.6. Market estimates and forecast by platform, 2018 - 2030 (Revenue, USD Billion)
    • 9.3.8. Germany
      • 9.3.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.8.2. Market estimates and forecast by product type, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.8.3. Market estimates and forecast by therapeutic Areas, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.8.4. Market estimates and forecast by type, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.8.5. Market estimates and forecast by channel type, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.8.6. Market estimates and forecast by platform, 2018 - 2030 (Revenue, USD Billion)
    • 9.3.9. France
      • 9.3.9.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.9.2. Market estimates and forecast by product type, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.9.3. Market estimates and forecast by therapeutic Areas, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.9.4. Market estimates and forecast by type, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.9.5. Market estimates and forecast by channel type, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.9.6. Market estimates and forecast by platform, 2018 - 2030 (Revenue, USD Billion)
    • 9.3.10. Italy
      • 9.3.10.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.10.2. Market estimates and forecast by product type, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.10.3. Market estimates and forecast by therapeutic Areas, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.10.4. Market estimates and forecast by type, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.10.5. Market estimates and forecast by channel type, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.10.6. Market estimates and forecast by platform, 2018 - 2030 (Revenue, USD Billion)
    • 9.3.11. Spain
      • 9.3.11.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.11.2. Market estimates and forecast by product type, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.11.3. Market estimates and forecast by therapeutic Areas, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.11.4. Market estimates and forecast by type, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.11.5. Market estimates and forecast by channel type, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.11.6. Market estimates and forecast by platform, 2018 - 2030 (Revenue, USD Billion)
    • 9.3.12. Russia
      • 9.3.12.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.12.2. Market estimates and forecast by product type, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.12.3. Market estimates and forecast by therapeutic Areas, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.12.4. Market estimates and forecast by type, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.12.5. Market estimates and forecast by channel type, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.12.6. Market estimates and forecast by platform, 2018 - 2030 (Revenue, USD Billion)
    • 9.3.13. Poland
      • 9.3.13.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.13.2. Market estimates and forecast by product type, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.13.3. Market estimates and forecast by therapeutic Areas, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.13.4. Market estimates and forecast by type, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.13.5. Market estimates and forecast by channel type, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.13.6. Market estimates and forecast by platform, 2018 - 2030 (Revenue, USD Billion)
    • 9.3.14. Algeria
      • 9.3.14.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.14.2. Market estimates and forecast by product type, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.14.3. Market estimates and forecast by therapeutic Areas, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.14.4. Market estimates and forecast by type, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.14.5. Market estimates and forecast by channel type, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.14.6. Market estimates and forecast by platform, 2018 - 2030 (Revenue, USD Billion)
    • 9.3.15. Turkey
      • 9.3.15.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.15.2. Market estimates and forecast by product type, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.15.3. Market estimates and forecast by therapeutic Areas, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.15.4. Market estimates and forecast by type, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.15.5. Market estimates and forecast by channel type, 2018 - 2030 (Revenue, USD Billion)
      • 9.3.15.6. Market estimates and forecast by platform, 2018 - 2030 (Revenue, USD Billion)
  • 9.4. Asia Pacific
    • 9.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 9.4.2. Market estimates and forecast by product type, 2018 - 2030 (Revenue, USD Billion)
    • 9.4.3. Market estimates and forecast by therapeutic Areas, 2018 - 2030 (Revenue, USD Billion)
    • 9.4.4. Market estimates and forecast by type, 2018 - 2030 (Revenue, USD Billion)
    • 9.4.5. Market estimates and forecast by channel type, 2018 - 2030 (Revenue, USD Billion)
    • 9.4.6. Market estimates and forecast by platform, 2018 - 2030 (Revenue, USD Billion)
    • 9.4.7. China
      • 9.4.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 9.4.7.2. Market estimates and forecast by product type, 2018 - 2030 (Revenue, USD Billion)
      • 9.4.7.3. Market estimates and forecast by therapeutic Areas, 2018 - 2030 (Revenue, USD Billion)
      • 9.4.7.4. Market estimates and forecast by type, 2018 - 2030 (Revenue, USD Billion)
      • 9.4.7.5. Market estimates and forecast by channel type, 2018 - 2030 (Revenue, USD Billion)
      • 9.4.7.6. Market estimates and forecast by platform, 2018 - 2030 (Revenue, USD Billion)
    • 9.4.8. India
      • 9.4.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 9.4.8.2. Market estimates and forecast by product type, 2018 - 2030 (Revenue, USD Billion)
      • 9.4.8.3. Market estimates and forecast by therapeutic Areas, 2018 - 2030 (Revenue, USD Billion)
      • 9.4.8.4. Market estimates and forecast by type, 2018 - 2030 (Revenue, USD Billion)
      • 9.4.8.5. Market estimates and forecast by channel type, 2018 - 2030 (Revenue, USD Billion)
      • 9.4.8.6. Market estimates and forecast by platform, 2018 - 2030 (Revenue, USD Billion)
    • 9.4.9. Japan
      • 9.4.9.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 9.4.9.2. Market estimates and forecast by product type, 2018 - 2030 (Revenue, USD Billion)
      • 9.4.9.3. Market estimates and forecast by therapeutic Areas, 2018 - 2030 (Revenue, USD Billion)
      • 9.4.9.4. Market estimates and forecast by type, 2018 - 2030 (Revenue, USD Billion)
      • 9.4.9.5. Market estimates and forecast by channel type, 2018 - 2030 (Revenue, USD Billion)
      • 9.4.9.6. Market estimates and forecast by platform, 2018 - 2030 (Revenue, USD Billion)
    • 9.4.10. Australia
      • 9.4.10.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 9.4.10.2. Market estimates and forecast by product type, 2018 - 2030 (Revenue, USD Billion)
      • 9.4.10.3. Market estimates and forecast by therapeutic Areas, 2018 - 2030 (Revenue, USD Billion)
      • 9.4.10.4. Market estimates and forecast by type, 2018 - 2030 (Revenue, USD Billion)
      • 9.4.10.5. Market estimates and forecast by channel type, 2018 - 2030 (Revenue, USD Billion)
      • 9.4.10.6. Market estimates and forecast by platform, 2018 - 2030 (Revenue, USD Billion)
    • 9.4.11. South Korea
      • 9.4.11.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 9.4.11.2. Market estimates and forecast by product type, 2018 - 2030 (Revenue, USD Billion)
      • 9.4.11.3. Market estimates and forecast by therapeutic Areas, 2018 - 2030 (Revenue, USD Billion)
      • 9.4.11.4. Market estimates and forecast by type, 2018 - 2030 (Revenue, USD Billion)
      • 9.4.11.5. Market estimates and forecast by channel type, 2018 - 2030 (Revenue, USD Billion)
      • 9.4.11.6. Market estimates and forecast by platform, 2018 - 2030 (Revenue, USD Billion)
    • 9.4.12. Indonesia
      • 9.4.12.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 9.4.12.2. Market estimates and forecast by product type, 2018 - 2030 (Revenue, USD Billion)
      • 9.4.12.3. Market estimates and forecast by therapeutic Areas, 2018 - 2030 (Revenue, USD Billion)
      • 9.4.12.4. Market estimates and forecast by type, 2018 - 2030 (Revenue, USD Billion)
      • 9.4.12.5. Market estimates and forecast by channel type, 2018 - 2030 (Revenue, USD Billion)
      • 9.4.12.6. Market estimates and forecast by platform, 2018 - 2030 (Revenue, USD Billion)
  • 9.5. Latin America
    • 9.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 9.5.2. Market estimates and forecast by product type, 2018 - 2030 (Revenue, USD Billion)
    • 9.5.3. Market estimates and forecast by therapeutic Areas, 2018 - 2030 (Revenue, USD Billion)
    • 9.5.4. Market estimates and forecast by type, 2018 - 2030 (Revenue, USD Billion)
    • 9.5.5. Market estimates and forecast by channel type, 2018 - 2030 (Revenue, USD Billion)
    • 9.5.6. Market estimates and forecast by platform, 2018 - 2030 (Revenue, USD Billion)
    • 9.5.7. Brazil
      • 9.5.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 9.5.7.2. Market estimates and forecast by product type, 2018 - 2030 (Revenue, USD Billion)
      • 9.5.7.3. Market estimates and forecast by therapeutic Areas, 2018 - 2030 (Revenue, USD Billion)
      • 9.5.7.4. Market estimates and forecast by type, 2018 - 2030 (Revenue, USD Billion)
      • 9.5.7.5. Market estimates and forecast by channel type, 2018 - 2030 (Revenue, USD Billion)
      • 9.5.7.6. Market estimates and forecast by platform, 2018 - 2030 (Revenue, USD Billion)
    • 9.5.8. Mexico
      • 9.5.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 9.5.8.2. Market estimates and forecast by product type, 2018 - 2030 (Revenue, USD Billion)
      • 9.5.8.3. Market estimates and forecast by therapeutic Areas, 2018 - 2030 (Revenue, USD Billion)
      • 9.5.8.4. Market estimates and forecast by type, 2018 - 2030 (Revenue, USD Billion)
      • 9.5.8.5. Market estimates and forecast by channel type, 2018 - 2030 (Revenue, USD Billion)
      • 9.5.8.6. Market estimates and forecast by platform, 2018 - 2030 (Revenue, USD Billion)
  • 9.6. Middle East & Africa
    • 9.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 9.6.2. Market estimates and forecast by product type, 2018 - 2030 (Revenue, USD Billion)
    • 9.6.3. Market estimates and forecast by therapeutic Areas, 2018 - 2030 (Revenue, USD Billion)
    • 9.6.4. Market estimates and forecast by type, 2018 - 2030 (Revenue, USD Billion)
    • 9.6.5. Market estimates and forecast by channel type, 2018 - 2030 (Revenue, USD Billion)
    • 9.6.6. Market estimates and forecast by platform, 2018 - 2030 (Revenue, USD Billion)
    • 9.6.7. Saudi Arabia
      • 9.6.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 9.6.7.2. Market estimates and forecast by product type, 2018 - 2030 (Revenue, USD Billion)
      • 9.6.7.3. Market estimates and forecast by therapeutic Areas, 2018 - 2030 (Revenue, USD Billion)
      • 9.6.7.4. Market estimates and forecast by type, 2018 - 2030 (Revenue, USD Billion)
      • 9.6.7.5. Market estimates and forecast by channel type, 2018 - 2030 (Revenue, USD Billion)
      • 9.6.7.6. Market estimates and forecast by platform, 2018 - 2030 (Revenue, USD Billion)
    • 9.6.8. South Africa
      • 9.6.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 9.6.8.2. Market estimates and forecast by product type, 2018 - 2030 (Revenue, USD Billion)
      • 9.6.8.3. Market estimates and forecast by therapeutic Areas, 2018 - 2030 (Revenue, USD Billion)
      • 9.6.8.4. Market estimates and forecast by type, 2018 - 2030 (Revenue, USD Billion)
      • 9.6.8.5. Market estimates and forecast by channel type, 2018 - 2030 (Revenue, USD Billion)
      • 9.6.8.6. Market estimates and forecast by platform, 2018 - 2030 (Revenue, USD Billion)

Chapter 10. Competitive Landscape

  • 10.1. Company Categorization (Mature Players, Emerging Players)
  • 10.2. Company Share Analysis, 2022
  • 10.3. Heat Map Analysis
  • 10.4. Strategy Mapping
  • 10.5. Company Profiles (Overview, Financial Performance, Product Overview, Strategic Initiatives)
    • 10.5.1. Amazon, Inc
    • 10.5.2. Apotek
    • 10.5.3. CVS Health
    • 10.5.4. DocMorris
    • 10.5.5. Express Scripts
    • 10.5.6. Giant Eagle, Inc.
    • 10.5.7. L Rowland & Co (Retail) Ltd
    • 10.5.8. McKesson Corporation
    • 10.5.9. Netmeds Marketplace Ltd.
    • 10.5.10. Optum, Inc.
    • 10.5.11. SHOP-APOTHEKE EUROPE N.V.
    • 10.5.12. The Kroger Co.
    • 10.5.13. Walmart
    • 10.5.14. Walgreens Boots Alliance, Inc.
    • 10.5.15. Zur Rose Group AG